Efficacy of Aflibercept versus Ranibizumab in the treatment of diabetic macular edema
AIM: To observe the efficacy of aflibercept and ranibizumab in the treatment of diabetic macular edema(DME).METHODS: Patients with DME who visited the ophthalmology department of Xingtai People's Hospital for the first time from November 2019 to February 2020 were included in the study. They we...
Saved in:
Main Authors: | Xiu-Xian Wang, Pei-Cheng Zhang, Jing Xie, Xiang-Rong Zuo |
---|---|
Format: | article |
Language: | EN |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/aa28b6b9770a40eb851da109dcc786dd |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
by: Fouda SM, et al.
Published: (2017) -
Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
by: Pessoa B, et al.
Published: (2021) -
Intravitreal Aflibercept versus Laser Photocoagulation in Asian Patients with Diabetic Macular Edema: The VIVID-East Study
by: Chen YX, et al.
Published: (2020) -
Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion
by: Tagami M, et al.
Published: (2017) -
Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab
by: Nudleman E, et al.
Published: (2016)